Casein Kinase 2 Inhibitors Pipeline Insights 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Casein Kinase 2 Inhibitors - Pipeline Insights, 2017" drug pipelines to their offering.

Casein Kinase 2 Inhibitors - Pipeline Insights, 2017 provides in depth insights on the pipeline drugs and their development activities around the Casein Kinase 2 Inhibitors. This report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.

Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. This report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Casein Kinase 2 Inhibitors.

This report also assesses the Casein Kinase 2 Inhibitors therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Scope:

  • The report provides competitivepipeline landscape of Casein Kinase 2 Inhibitors
  • The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
  • Coverage of the Casein Kinase 2 Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Casein Kinase 2 Inhibitors and also provide company profiling
  • The report also gives the information of dormant and discontinued pipeline projects
  • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Key Topics Covered:

  1. Casein Kinase 2 Inhibitors Overview
  2. Casein Kinase 2 Inhibitors Pipeline Therapeutics
  3. Casein Kinase 2 Inhibitors Therapeutics under Development by Companies
  4. Casein Kinase 2 Inhibitors Filed and Phase III Products
  5. Casein Kinase 2 Inhibitors Phase II Products
  6. Casein Kinase 2 Inhibitors Phase I and IND Filed Products
  7. Casein Kinase 2 Inhibitors Discovery and Pre-Clinical Stage Products
  8. Drug Candidate Profiles
  9. Casein Kinase 2 Inhibitors - Therapeutics Assessment
  10. Companies Involved in Therapeutics Development for Casein Kinase 2 Inhibitors
  11. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/4xfjm2/casein_kinase_2

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Enzymes

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Enzymes